𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Null association between pregnancy termination and breast cancer in a registry-based study of parous women

✍ Scribed by Timothy L. Lash; Aliza K. Fink


Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
86 KB
Volume
110
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Studies suggesting a positive association between pregnancy termination and breast cancer risk have often been of retrospective case‐control design, so subject to selection and recall biases. We undertook a registry‐based analysis with minimal selection bias and prospective record‐based ascertainment of terminations. The source population comprised Massachusetts women with a record of giving birth between 1987 and 1999 in the Massachusetts Vital Statistics Registry. Primary breast cancer cases were 25–55 years old at diagnosis between 1988 and 2000 and had a record of the diagnosis in the Massachusetts Cancer Registry. We matched 3 controls to each case on maternal age, year of giving birth and birth facility. Information on terminations (induced and spontaneous) before the birth of record, the matched factors and potential confounders were collected from the birth certificate. After adjustment for the matched factors, age, parity and maternal and paternal education, the odds ratio associating any termination history with breast cancer risk equaled 0.91 (95% CI = 0.79–1.05). The marginally protective adjusted odds ratio largely derived from a protective effect among women with parity equaled to 1 (OR for any termination = 0.68; 95% CI = 0.45–1.03), suggesting a protective effect of terminated pregnancy among women with one live birth. © 2004 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Large differences in patterns of breast
✍ Laura M. Woods; Bernard Rachet; Dianne O'Connell; Gill Lawrence; Elizabeth Trace 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 256 KB 👁 1 views

## Abstract Survival from breast cancer in the UK is lower than in other countries in Western Europe, the USA and Australia. However, these international differences have not yet been examined in relation to tumor characteristics, treatment, screening history or other prognostic factors. We calcula

Association between standard clinical an
✍ Ido Wolf; Noa Ben-Baruch; Ronnie Shapira-Frommer; Shulamit Rizel; Hadassa Goldbe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND. The 21‐gene recurrence score (RS) assay has been reported to accurately predict the risk of disease recurrence and chemotherapy benefit in women with estrogen receptor (ER)‐positive, lymph node (LN)‐negative breast cancer who are treated with tamoxifen. To the authors' k

Development in incidence of breast cance
✍ Niels Fuglede; Oline Langballe; Anne Louise Svendsen; Anne Tjønneland; Susanne O 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 87 KB

## Abstract The authors report on the incidence rates of breast cancer overall and by histology in a population of unscreened women constituting ∼80% of the total population of women in Denmark from 1973–2002, utilizing the files of the nationwide Danish Cancer Registry. The age‐specific incidence

Lifelong vegetarianism and risk of breas
✍ Isabel dos Santos Silva; Punam Mangtani; Valerie McCormack; Dee Bhakta; Leena Se 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 2 views

## Abstract To investigate the role of lifelong vegetarianism on the aetiology of female breast cancer, we conducted a population‐based case‐control study among South Asian migrant women from the Indian subcontinent resident in England. A total of 240 South Asian breast cancer cases were identified

Contribution of BRCA1 and BRCA2 germ-lin
✍ Valerie Bonadona; Olga M. Sinilnikova; Sandrine Chopin; Antonis C. Antoniou; Her 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e